BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28748716)

  • 1. Late urinary morbidity and quality of life after radical prostatectomy and salvage radiotherapy for prostate cancer
    Ervandian M; Høyer M; Petersen SE; Sengeløv L; Hansen S; Kempel MM; Meidahl Petersen P; Borre M
    Scand J Urol; 2017 Dec; 51(6):457-463. PubMed ID: 28748716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term urodynamic findings following radical prostatectomy and salvage radiotherapy.
    Ervandian M; Djurhuus JC; Høyer M; Graugaard-Jensen C; Borre M
    Scand J Urol; 2018 Feb; 52(1):20-26. PubMed ID: 28748746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients.
    van Stam MA; Aaronson NK; Pos FJ; Bosch JL; Kieffer JM; Tillier CN; van der Poel HG
    Eur Urol; 2016 Nov; 70(5):751-757. PubMed ID: 27016464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy.
    Lilleby W; Fosså SD; Waehre HR; Olsen DR
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):735-43. PubMed ID: 10098428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early salvage radiation therapy combined with short-term hormonal therapy in recurrent prostate cancer after radical prostatectomy: single-institution 4-year data on outcome, toxicity, health-related quality of life and co-morbidities from 184 consecutive patients treated with 70 Gy.
    Cortés-González JR; Castellanos E; Sandberg K; Eriksson MH; Wiklund P; Carlsson S; Cohn-Cedermark G; Harmenberg U; Gustafsson O; Levitt SH; Lennernäs B; Brandberg Y; Márquez M; Kälkner KM; Nilsson S
    Int J Oncol; 2013 Jan; 42(1):109-17. PubMed ID: 23151842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in lower urinary tract symptoms and quality of life after salvage radiotherapy for biochemical recurrence of prostate cancer.
    Miyake M; Tanaka N; Asakawa I; Tatsumi Y; Nakai Y; Anai S; Torimoto K; Aoki K; Yoneda T; Hasegawa M; Konishi N; Fujimoto K
    Radiother Oncol; 2015 Jun; 115(3):321-6. PubMed ID: 25991382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime.
    Nyarangi-Dix JN; Steimer J; Bruckner T; Jakobi H; Koerber SA; Hadaschik B; Debus J; Hohenfellner M
    World J Urol; 2017 Dec; 35(12):1841-1847. PubMed ID: 28861691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer.
    Bradley EB; Bissonette EA; Theodorescu D
    BJU Int; 2004 Nov; 94(7):1003-9. PubMed ID: 15541117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overactive Bladder and Storage Lower Urinary Tract Symptoms Following Radical Prostatectomy.
    Hosier GW; Tennankore KK; Himmelman JG; Gajewski J; Cox AR
    Urology; 2016 Aug; 94():193-7. PubMed ID: 27181241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer.
    Krupski T; Petroni GR; Bissonette EA; Theodorescu D
    Urology; 2000 May; 55(5):736-42. PubMed ID: 10792092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 3-y prospective study of health-related and disease-specific quality of life in patients with nonmetastatic prostate cancer treated with radical prostatectomy or external beam radiotherapy.
    Yoshimura K; Arai Y; Ichioka K; Matsui Y; Ogura K; Terai A
    Prostate Cancer Prostatic Dis; 2004; 7(2):144-51. PubMed ID: 15111981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10.
    Ghadjar P; Hayoz S; Bernhard J; Zwahlen DR; Stein J; Hölscher T; Gut P; Polat B; Hildebrandt G; Müller AC; Putora PM; Papachristofilou A; Schär C; Dal Pra A; Biaggi Rudolf C; Wust P; Aebersold DM; Thalmann GN;
    Radiother Oncol; 2018 Feb; 126(2):257-262. PubMed ID: 29103826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life after radical prostatectomy and low-dose-rate brachytherapy for localized prostate cancer.
    Wyler SF; Engeler DS; Seelentag W; Ries G; Schmid HP
    Urol Int; 2009; 82(1):17-23. PubMed ID: 19172091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Less satisfaction with information in patients with prostate cancer treated with surgery and salvage radiotherapy compared with patients treated with curative radiotherapy alone, despite similar health-related quality of life.
    Majumder K; Brandberg Y; Johansson H; Nilsson S; Bergenmar M
    Clin Genitourin Cancer; 2014 Jun; 12(3):e71-82. PubMed ID: 24445250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses.
    Abuodeh YA; Naghavi AO; Juan TH; Ma Z; Wilder RB
    Int Braz J Urol; 2017; 43(4):628-637. PubMed ID: 28379660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10.
    Ghadjar P; Hayoz S; Bernhard J; Zwahlen DR; Hölscher T; Gut P; Guckenberger M; Hildebrandt G; Müller AC; Plasswilm L; Papachristofilou A; Stalder L; Biaggi-Rudolf C; Sumila M; Kranzbühler H; Najafi Y; Ost P; Azinwi NC; Reuter C; Bodis S; Kaouthar K; Wust P; Thalmann GN; Aebersold DM
    J Clin Oncol; 2015 Dec; 33(35):4158-66. PubMed ID: 26527774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
    Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy.
    Beck M; Wust P; Barelkowski T; Kaul D; Thieme AH; Wecker S; Wlodarczyk W; Budach V; Ghadjar P
    Radiat Oncol; 2017 Aug; 12(1):125. PubMed ID: 28793907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
    Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
    Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in men with localized prostate cancer treated by radical prostatectomy or radiotherapy.
    Rodgers JK; Sawhney R; Chaudhary U; Bissada NK
    Arch Androl; 2006; 52(2):129-33. PubMed ID: 16443590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.